Embio Diagnostics
PrivateLast Round
Grant
Jun 4, 2026
Total Funding Raised
$3.88M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Embio Diagnostics operates in Healthcare & Life Sciences and is based in Nicosia. Its latest recorded funding round was a Grant round in June 2026.
Embio Diagnostics is a biotechnology company that designs and develops portable, biosensor-based, and digital devices for rapid diagnostics in food safety, air quality, and environmental research.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Environmental Monitoring, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Embio Diagnostics Comparables
Compare Embio Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioEclosion | 75% | |
| LuminUltra | 71% | |
| EW Group | 68% |
For institutional investors. Book with your work email.
Embio Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 4, 2026 | ||||
| Grant | Mar 2, 2026 | ||||
| Seed | Nov 15, 2024 | ||||
| Seed | Dec 13, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Embio Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Kinisis Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
Received funding from the European Innovation Council.
- Apr 19, 2026
Grew 15% QoQ from 26 to 30 employees.
For institutional investors. Book with your work email.
Embio Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Embio Diagnostics's valuation, stock price, and market status.
Is Embio Diagnostics a public or private company?
Embio Diagnostics is a private company.
What is the current stock price of Embio Diagnostics?
Embio Diagnostics is a private company, so its shares have no public market price. Caplight tracks Embio Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Embio Diagnostics worth (valuation)?
Valuation information for Embio Diagnostics is not publicly available.
Can I buy Embio Diagnostics stock?
Embio Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Embio Diagnostics's last funding round?
Embio Diagnostics's most recent funding round was Grant on June 4, 2026.
Who are the main investors in Embio Diagnostics?
Key investors in Embio Diagnostics include Kinisis Ventures.
Will Embio Diagnostics IPO soon?
No public IPO plans have been announced for Embio Diagnostics.
How can I track Embio Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Embio Diagnostics's shares on secondary markets.